7Baggers
 3 promising penny stocks with market caps below $600m  Yahoo Finance Fri, 07 Nov 2025 18:05:09 GMT
 black diamond: q3 earnings snapshot  Norwalk Hour Fri, 07 Nov 2025 00:54:24 GMT
 BDTX to Provide Clinical Update on Silevertinib Phase 2 Trial  GuruFocus Thu, 06 Nov 2025 13:10:31 GMT
 Black Diamond (BDTX) Projects Financial Stability Through 2027  GuruFocus Thu, 06 Nov 2025 13:10:21 GMT
 Black Diamond Therapeutics Inc Reports Q3 2025 EPS of -$0.15, Be  GuruFocus Thu, 06 Nov 2025 12:50:13 GMT
 Black Diamond narrows Q3 net loss as R&D costs drop  MarketScreener Thu, 06 Nov 2025 08:00:00 GMT
 Black Diamond: Q3 Earnings Snapshot  San Francisco Chronicle Thu, 06 Nov 2025 08:00:00 GMT
 will black diamond therapeutics inc. stock maintain momentum in 2025  Fundação Cultural do Pará Wed, 05 Nov 2025 23:43:44 GMT
 Should You Buy, Hold, or Sell BDTX Stock Ahead of Q3 Earnings?  Zacks Investment Research Fri, 31 Oct 2025 07:00:00 GMT
 published on: 2025-10-28 09:38:06  newser.com Tue, 28 Oct 2025 14:38:06 GMT
 published on: 2025-10-27 19:48:31  newser.com Tue, 28 Oct 2025 00:48:31 GMT
 published on: 2025-10-26 22:14:09  newser.com Mon, 27 Oct 2025 03:14:09 GMT
 published on: 2025-10-25 05:50:38  newser.com Sat, 25 Oct 2025 10:50:38 GMT
 published on: 2025-10-25 01:50:20  newser.com Sat, 25 Oct 2025 06:50:20 GMT

Black Diamond Therapeutics, Inc
(NASDAQ:BDTX) 

BDTX stock logo

Black Diamond Therapeutics, Inc., a biotechnology company, discover and develops small molecule, tumor-agnostic therapies. Its lead product candidate is BDTX-189, an irreversible small molecule inhibitor that is designed to block the function of family of oncogenic proteins defined by driver mutatio...

Founded: 2017
Full Time Employees: 58
CEO: David M. Epstein  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends